Argenx Se Stock News

Biotech stocks are risky investments and to make a profit informed decision-making is needed. BofA Securities announced its top mid-cap biopharma picks in a note released Tuesday. The Biopharma Analy

Biotech stocks are risky investments and to make a profit informed decision-making is needed. BofA Securities announced its top mid-cap biopharma picks in a note released Tuesday.

Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple conference presentations

Analysts predict that argenx SE (NASDAQ:ARGX) will post earnings of ($5.06) per share for the current quarter, according to Zacks. Four analysts have made estimates for argenxs earnings. The highest EPS estimate is ($4.08) and the lowest is ($6.71). argenx reported earnings per share of ($4.20) during the same quarter last year, which suggests a []

Wells Fargo & Company MN lowered its position in argenx SE (NASDAQ:ARGX) by 12.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 23,611 shares of the companys stock after selling 3,506 shares during the period. Wells Fargo & Company MNs holdings []

argenx SE (NASDAQ:ARGX) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 1,000,000 shares, a growth of 32.7% from the October 31st total of 753,400 shares. Approximately 2.0% of the shares of the stock are short sold. Based on an []

A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for the year-to-date peri

argenx SE (NASDAQ:ARGX) Stock analysts at Piper Sandler lowered their FY2021 earnings estimates for shares of argenx in a report issued on Monday, November 29th. Piper Sandler analyst E. Tenthoff now anticipates that the company will post earnings per share of ($8.54) for the year, down from their prior forecast of ($8.13). Piper Sandler []

Wall Street brokerages predict that argenx SE (NASDAQ:ARGX) will announce $10.23 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for argenxs earnings, with the lowest sales estimate coming in at $5.70 million and the highest estimate coming in at $14.00 million. argenx posted sales of $7.59 []

Analysts predict that argenx SE (NASDAQ:ARGX) will announce earnings per share (EPS) of ($5.05) for the current quarter, according to Zacks. Four analysts have made estimates for argenxs earnings, with estimates ranging from ($6.71) to ($4.08). argenx posted earnings per share of ($4.20) in the same quarter last year, which would indicate a negative year-over-year []

Cubist Systematic Strategies LLC increased its position in shares of argenx SE (NASDAQ:ARGX) by 141.3% in the second quarter, Holdings Channel reports. The institutional investor owned 1,349 shares of the companys stock after buying an additional 790 shares during the period. Cubist Systematic Strategies LLCs holdings in argenx were worth $406,000 as of its most []

Wall Street brokerages expect argenx SE (NASDAQ:ARGX) to announce $10.23 million in sales for the current quarter, according to Zacks. Four analysts have issued estimates for argenxs earnings. The lowest sales estimate is $5.70 million and the highest is $14.00 million. argenx posted sales of $7.59 million in the same quarter last year, which suggests []

State Street Corp reduced its holdings in argenx SE (NASDAQ:ARGX) by 8.9% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 50,865 shares of the companys stock after selling 4,968 shares during the period. State Street Corps holdings in argenx were worth $15,314,000 as of its most recent filing with the Securities & Exchange []

Baron funds took big stakes in Nvidia, Sea, Shopify and other companies in the third quarter.